GE HealthCare Technologies (GEHC) Expected to Announce Quarterly Earnings on Wednesday

GE HealthCare Technologies (NASDAQ:GEHC) is anticipated to post its Q2 2026 results before the market opens on Wednesday, July 29th. Analysts expect GE HealthCare Technologies to post earnings of $1.04 per share and revenue of $5.2637 billion for the quarter. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Interested persons may review the information on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 8:30 AM ET.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). The company had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.01 EPS. On average, analysts expect GE HealthCare Technologies to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

GE HealthCare Technologies Stock Up 0.9%

Shares of GEHC opened at $61.12 on Tuesday. The company has a market cap of $27.80 billion, a PE ratio of 14.62, a P/E/G ratio of 1.65 and a beta of 0.72. The business has a fifty day moving average of $63.63 and a 200 day moving average of $70.96. GE HealthCare Technologies has a 52-week low of $58.75 and a 52-week high of $89.77. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be given a dividend of $0.035 per share. The ex-dividend date is Friday, July 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is 3.35%.

Insiders Place Their Bets

In other GE HealthCare Technologies news, Director Kevin Lobo acquired 10,000 shares of the company’s stock in a transaction dated Friday, May 22nd. The shares were purchased at an average cost of $64.18 per share, for a total transaction of $641,800.00. Following the completion of the purchase, the director owned 14,363 shares in the company, valued at approximately $921,817.34. This trade represents a 229.20% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CFO James Saccaro acquired 3,310 shares of the business’s stock in a transaction that occurred on Friday, May 1st. The shares were acquired at an average cost of $60.60 per share, for a total transaction of $200,586.00. Following the completion of the acquisition, the chief financial officer owned 87,471 shares of the company’s stock, valued at $5,300,742.60. This trade represents a 3.93% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders have purchased 21,847 shares of company stock worth $1,361,355. 0.36% of the stock is owned by corporate insiders.

Institutional Trading of GE HealthCare Technologies

A number of hedge funds have recently bought and sold shares of the stock. Dodge & Cox boosted its position in GE HealthCare Technologies by 13.4% during the 4th quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock valued at $2,559,945,000 after acquiring an additional 3,693,918 shares in the last quarter. State Street Corp increased its holdings in shares of GE HealthCare Technologies by 2.0% in the 4th quarter. State Street Corp now owns 20,049,677 shares of the company’s stock valued at $1,644,475,000 after acquiring an additional 401,932 shares during the period. Hotchkis & Wiley Capital Management LLC raised its position in shares of GE HealthCare Technologies by 17.1% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 8,432,374 shares of the company’s stock worth $633,271,000 after acquiring an additional 1,232,828 shares in the last quarter. Invesco Ltd. raised its position in shares of GE HealthCare Technologies by 1.6% in the 4th quarter. Invesco Ltd. now owns 7,003,172 shares of the company’s stock worth $574,400,000 after acquiring an additional 112,028 shares in the last quarter. Finally, Barrow Hanley Mewhinney & Strauss LLC purchased a new stake in shares of GE HealthCare Technologies during the 4th quarter worth $533,655,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently weighed in on GEHC. Zacks Research downgraded shares of GE HealthCare Technologies from a “hold” rating to a “strong sell” rating in a research note on Tuesday, July 21st. Mizuho dropped their price target on shares of GE HealthCare Technologies from $90.00 to $80.00 in a research note on Thursday, April 30th. JPMorgan Chase & Co. cut their price target on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a report on Thursday, April 30th. BMO Capital Markets started coverage on shares of GE HealthCare Technologies in a research report on Wednesday, July 8th. They issued a “market perform” rating and a $70.00 price objective on the stock. Finally, Wells Fargo & Company decreased their price objective on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a research note on Thursday, April 30th. Ten analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, GE HealthCare Technologies has an average rating of “Hold” and a consensus price target of $76.41.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.